Cross-sectional study of patient satisfaction with oral analgesics in patients with chronic pain in Japan-Reference-Cited by-同舟云学术

Cross-sectional study of patient satisfaction with oral analgesics in patients with chronic pain in Japan

Published:2020-04-06 Issue:8 Volume:21 Page:983-991
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Ushida Takahiro¹,Inoue Teruyoshi²,Matsui Daiju²,Yokoyama Mizuka²,Shiosakai Kazuhito³,Takeda Kuniyuki⁴,Fukuoka Katsushi⁵,Nakagawa Osamu⁶,Okuizumi Kaoru²^ORCID

Affiliation:

1. Multidisciplinary Pain Center, Aichi Medical University, Nagakute, Japan

2. Medical Science Department, Medical Affairs Division, Daiichi Sankyo Co., Ltd, Tokyo, Japan

3. Biostatistics & Data Management Department, Research and Development Division, Daiichi Sankyo Co., Ltd, Tokyo, Japan

4. Sales Planning Group, Japan Medical Research Institute Co., Ltd., Tokyo, Japan

5. Educational Training & Medical Information Department, Nihon Chouzai Co., Ltd., Tokyo, Japan

6. The Agent LLC., Tokyo, Japan

Funder

Daiichi Sankyo Co., Ltd

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1743267

Reference16 articles.

1. Musculoskeletal pain and incident disability in community-dwelling older adults

2. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment

3. Recent prescription status of oral analgesics in Japan in real-world clinical settings: retrospective study using a large-scale prescription database

4. GP and Patient Perspectives on Treatment with Non-steroidal Anti-inflammatory Drugs for the Treatment of Pain in Osteoarthritis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A large-scale database study for the prescription status of a new voltage-gated Ca2+ channel α2δ ligand, mirogabalin, in Japan;Expert Opinion on Pharmacotherapy;2021-12-20

2. A review of a new voltage-gated Ca2+ channel α2δ ligand, mirogabalin, for the treatment of peripheral neuropathic pain;Expert Opinion on Pharmacotherapy;2021-08-25

3. A Cross-Sectional Web Survey of Satisfaction with Treatment for Pain in Participants with Suspected Diabetic Peripheral Neuropathic Pain in Both Feet;Advances in Therapy;2021-07-08